Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DX8SNS
|
||||
Drug Name |
2-[3-(1H-Indol-6-yl)-phenyl]-4-methyl-pentanoic acid cyanomethyl-amide
|
||||
Synonyms |
CHEMBL122318
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C22H23N3O
|
||||
Canonical SMILES |
CC(C)CC(C(=O)NCC#N)c1cccc(c1)c2ccc3cc[nH]c3c2
|
||||
InChI |
InChI=1S/C22H23N3O/c1-15(2)12-20(22(26)25-11-9-23)19-5-3-4-17(13-19)18-7-6-16-8-10-24-21(16)14-18/h3-8,10,13-15,20,24H,11-12H2,1-2H3,(H,25,26)
|
||||
InChIKey |
QBNGROARPWCXCH-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Cathepsin K | Target Info | [1587926] | ||
Cathepsin L | Target Info | [1587926] | |||
Reactome | Collagen degradation | ||||
Degradation of the extracellular matrix | |||||
Activation of Matrix Metalloproteinases | |||||
Trafficking and processing of endosomal TLR | |||||
MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
Assembly of collagen fibrils and other multimeric structures | |||||
MHC class II antigen presentation | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.